Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Patients with Pancreatic Neuroendocrine Tumours (PanNETs) often have a good prognosis with long overall survival.
Conference:
Presenting Author: Milanetto A
Authors: Milanetto A, Armellin C, Veronese E, Lorenzoni G, Pasquali C,
Keywords: net, pancreatic, quality of life,
Introduction: Pancreatic neuroendocrine neoplasms (P-NENs) are a group of tumours originating from pancreatic neuroendocrine cells. Although these tumours are relatively rare, studies on them have gradually increased in recent years.
Conference:
Presenting Author:
Keywords: Pancreatic neuroendocrine neoplasm, Multivariate analysis, Surgery,
Introduction: Rectal neuroendocrine tumor (RNET) is common second only to pancreatic neuroendocrine tumor in Chinese population. Some studies demonstrated that 18F-FDG PET/CT is useful for risk stratification of GEP-NET and is even better than histologic grade to predict the prognosis.
Conference:
Presenting Author: Xu J
Authors: Xu J, Xu X, Liang Y, Huang D, Chen J,
Keywords: rectal neuroendocrine tumor, 68Ga-DOTANOC, 18F-FDG, PET/CT, prognosis,
Introduction: Tumor Growth Rate (TGR) allows for early SSA and RLT response assessment in NET.
Conference:
Presenting Author: Scalorbi F
Authors: Scalorbi F, Calareso G, Garanzini E, Prinzi N, Pusceddu S,
#3457 Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms
Introduction: There are only few, but controversial data on the prognostic role of upfront primary tumor resection and mesenteric lymph node dissection (PTR) in patients with stage IV small intestinal neuroendocrine neoplasia (SI-NEN).
Conference:
Presenting Author:
Authors: Maurer E, Heinzel-Gutenbrunner M, Rinke A, Rütz J, Figiel J,
Keywords: stage 4 small intestine neuroendocrine neoplasm, primary tumor resection, survival, peptide receptor radionuclide therapy,